Evaluation of therapeutic effects of adding memantine to stimulants in children with attention deficit hyperactivity disorder
Phase 3
Recruiting
- Conditions
- Attention-deficit hyperactivity disorder (ADHD).Attention-deficit hyperactivity disorder, unspecified typeF90.9
- Registration Number
- IRCT20200825048515N58
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Children with attention deficit hyperactivity disorder (ADHD)
Age range 6 to 12 years
Treated with methylphenidate
Parents' consent to participate in the study
Exclusion Criteria
Having major medical disorders (diabetes, asthma, heart disease, seizures)
Having a concomitant psychiatric disorder (mood and anxiety disorders and behavioral and confrontational disorders - disobedience)
Taking another drug in addition to a long-acting stimulant
Mental retardation
Drug sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method